All Curated Mutation Sites in HPV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E1
  
E1^E4
  
E2
  
E5
  
E6
  
E7
  
L1
  
L2
  

Keyword: Uterine Cervical Neoplasms-30161236
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 30161236 G43E
E7
E7
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
2 30161236 G88R
E7
E7
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
3 30161236 H51N
E7
E7
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
4 30161236 L28F
E7
E7
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
5 30161236 R66W
E7
E7
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
6 30161236 7137_7469del
E6
E6
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
7 30161236 D105H
E6
E6
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
8 30161236 D105Y
E6
E6
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
9 30161236 D71N
E6
E6
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
10 30161236 E120D
E6
E6
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
11 30161236 E36K
E6
E6
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
12 30161236 H31N
E6
E6
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
13 30161236 K4T
E6
E6
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
14 30161236 L90V
E6
E6
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
15 30161236 L95V
E6
E6
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
16 30161236 Q98R
E6
E6
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
17 30161236 R131T
E6
E6
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
18 30161236 R17G
E6
E6
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
19 30161236 R55W
E6
E6
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
20 30161236 R5G
E6
E6
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
21 30161236 S78C
E6
E6
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
22 30161236 T93K
E6
E6
Uterine Cervical Neoplasms
Oropharyngeal Neoplasms
G
R
L
View
Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.